Clinical trial registry record

Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Unknown.
Evidence
Registered phase 4 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated October 10, 2019.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT02976194
Last registry update
October 10, 2019
Status
Unknown
Phase
Phase 4
Sponsor
Pusan National University Hospital
Enrollment
28
Countries
South Korea
Match confidence
60%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE4 study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 4
Study design
NA · SINGLE GROUP · BASIC SCIENCE · NONE
Evidence population
Human clinical study registration
Participants
28
Population
ALL · 50 Years
Duration
2016-11-22 to 2020-01-01
Intervention
ranibizumab
Comparator
Not reported
Outcomes measured
Changes of VEGF-A from 8 weeks to 20 weeks — 8 weeks and 20 weeks; Changes of the other cytokines from 8 weeks to 20 weeks — 8 weeks and 20 weeks; Changes of cytokines from baseline to 8 weeks — baseline and 8 weeks; Correlation between time to recurrence and cytokine concentration at baseline and 8 weeks. — baseline and 8 weeks; Correlation between vision changes and cytokine concentration changes — baseline and 24 weeks.; Correlation between CSMT and cytokine concentration — baseline, 8 weeks and 20 weeks.; Correlation between choroidal thickness and cytokine concentration — baseline, 8 weeks and 20 weeks.; Correlation between area of new vessels and cytokine concentration — baseline; Correlation between polyp closure and cytokine concentration changes — baseline and 8 weeks
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 4A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 60% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Vision ageing · 60%Source terminology contains a controlled topic term. Source terminology supplies ageing or longevity context.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

vision aging
Read the original source →Export JSON